Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01400594 · ClinicalTrials.gov registry record · Phase 2
Safety & Efficacy Study of HTU-520 in the Treatment of Distal Subungual Onychomycosis of the Toenail
A Phase 2 study, sponsored by Hisamitsu Pharmaceutical Co..
- Completed
- Registry status
- Phase 2
- Development phase
- 182
- Enrollment target
NCT01400594 is a Phase 2 study that has completed, run by Hisamitsu Pharmaceutical Co.. The registered enrollment target is 182 participants.
The verdict
NCT01400594, a Phase 2 study, has completed, sponsored by Hisamitsu Pharmaceutical Co..
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 182 participants
- Enrollment target
Study Summary
This is a multicenter, randomized, double-blind, parallel-group, placebo-controlled study of HTU-520 in subjects with clinically diagnosed onychomycosis of the great toenail.
Interventions
- OTHER Placebo Patch
- DRUG HTU-520 Patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 182 participants |
| Start Date | 2011-07 |
| Est. Completion | 2013-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01400594
The ClinicalTrials.gov registry entry for NCT01400594 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 182 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hisamitsu Pharmaceutical Co., which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Patch is the first listed.
NCT01400594 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01400594 about?
NCT01400594 is a clinical study titled "Safety & Efficacy Study of HTU-520 in the Treatment of Distal Subungual Onychomycosis of the Toenail". This is a multicenter, randomized, double-blind, parallel-group, placebo-controlled study of HTU-520 in subjects with clinically diagnosed onychomycosis of the great toenail.
What is the current status of trial NCT01400594?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 182 participants. The study started on 2011-07. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01400594?
The interventions under investigation include: Placebo Patch (OTHER), HTU-520 Patch (DRUG).
Who is sponsoring clinical trial NCT01400594?
This trial is sponsored by Hisamitsu Pharmaceutical Co., which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.